Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2013-09, Vol.168 (2), p.1603-1605
Hauptverfasser:	Liu, Changle, Liu, Tong, Li, Guangping
Format:	Artikel
Sprache:	eng
Schlagworte:	Atrial fibrillation Atrial Fibrillation - blood Atrial Fibrillation - drug therapy Atrial Fibrillation - epidemiology Biological and medical sciences Cardiac dysrhythmias Cardiology. Vascular system Cardiovascular Diabetes mellitus Diabetes Mellitus - blood Diabetes Mellitus - drug therapy Diabetes Mellitus - epidemiology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Heart Humans Hypoglycemic Agents - therapeutic use Medical sciences Pioglitazone Thiazolidinediones - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!